These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 17960785)
1. First trimester screening for Down syndrome using free beta hCG, total hCG and PAPP-A: an exploratory study. Wright D; Spencer K; Nix B Prenat Diagn; 2007 Dec; 27(12):1118-22. PubMed ID: 17960785 [TBL] [Abstract][Full Text] [Related]
3. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509 [TBL] [Abstract][Full Text] [Related]
4. First trimester predictors of adverse pregnancy outcomes. Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038 [TBL] [Abstract][Full Text] [Related]
5. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays. Spencer K Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030 [TBL] [Abstract][Full Text] [Related]
6. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency. Bestwick JP; Huttly WJ; Wald NJ J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261 [TBL] [Abstract][Full Text] [Related]
7. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186 [TBL] [Abstract][Full Text] [Related]
9. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Krantz DA; Hallahan TW; Macri VJ; Macri JN Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986 [TBL] [Abstract][Full Text] [Related]
10. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600 [TBL] [Abstract][Full Text] [Related]
11. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Spencer K; Bindra R; Cacho AM; Nicolaides KH Prenat Diagn; 2004 Mar; 24(3):169-73. PubMed ID: 15057947 [TBL] [Abstract][Full Text] [Related]
12. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128 [TBL] [Abstract][Full Text] [Related]
13. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment. Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355 [TBL] [Abstract][Full Text] [Related]
14. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies. Ong CY; Lee CP; Leung KY; Lau E; Tang MH Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227 [TBL] [Abstract][Full Text] [Related]
15. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
16. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG. Casals E; Fortuny A; Grudzinskas JG; Suzuki Y; Teisner B; Comas C; Sanllehy C; Ojuel J; Borrell A; Soler A; Ballesta AM Prenat Diagn; 1996 May; 16(5):405-10. PubMed ID: 8843997 [TBL] [Abstract][Full Text] [Related]
17. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy. Palomaki GE; Neveux LM; Haddow JE; Wyatt P Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of first trimester Down syndrome screening studies: free beta-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol. Evans MI; Krantz DA; Hallahan TW; Galen RS Am J Obstet Gynecol; 2007 Mar; 196(3):198-205. PubMed ID: 17346522 [TBL] [Abstract][Full Text] [Related]
19. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency. Cowans NJ; Stamatopoulou A; Spencer K Prenat Diagn; 2009 May; 29(5):505-7. PubMed ID: 19222026 [TBL] [Abstract][Full Text] [Related]
20. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Krantz D; Goetzl L; Simpson JL; Thom E; Zachary J; Hallahan TW; Silver R; Pergament E; Platt LD; Filkins K; Johnson A; Mahoney M; Hogge WA; Wilson RD; Mohide P; Hershey D; Wapner R; Am J Obstet Gynecol; 2004 Oct; 191(4):1452-8. PubMed ID: 15507982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]